Cross Shawn sold PCRX
December 10, 2025 · Form 4 insider transaction
Cross Shawn sold 9,104 shares of Pacira BioSciences, Inc. at $25.14 per share, a transaction worth $228.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
9,104
Price
$25.14
Total value
$228.9K
InsiderCross Shawn
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 10, 2025
Filing dateDecember 11, 2025
Shares owned after56,250
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.30, inclusive.